Epilepsia mioclónica juvenil: benigna y crónica

juvenile myoclonic epilepsy represents 4.3-10.7% of all the epilepsies and it is pronounced at the beginning of the second decade of life. it is a genetic form with locus in the chromosome 6p. the evolution of the process is benign and the treatment is chronic with prolonged remission periods. the eegs are abnormal. we described the evolution of three patients of reference with myoclonic crisis and treatment durations of 11, 15 and 16 years, respectively. the election drugs were valproic acid and lamotrigine.